471 related articles for article (PubMed ID: 33643288)
1. Deposition of the Membrane Attack Complex in Healthy and Diseased Human Kidneys.
Koopman JJE; van Essen MF; Rennke HG; de Vries APJ; van Kooten C
Front Immunol; 2020; 11():599974. PubMed ID: 33643288
[TBL] [Abstract][Full Text] [Related]
2. Treatment of Rare Inflammatory Kidney Diseases: Drugs Targeting the Terminal Complement Pathway.
Anliker-Ort M; Dingemanse J; van den Anker J; Kaufmann P
Front Immunol; 2020; 11():599417. PubMed ID: 33362783
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical study of the C5b-9 complex of complement in human kidneys.
Hinglais N; Kazatchkine MD; Bhakdi S; Appay MD; Mandet C; Grossetete J; Bariety J
Kidney Int; 1986 Sep; 30(3):399-410. PubMed ID: 3537447
[TBL] [Abstract][Full Text] [Related]
4. An Ex Vivo Test of Complement Activation on Endothelium for Individualized Eculizumab Therapy in Hemolytic Uremic Syndrome.
Galbusera M; Noris M; Gastoldi S; Bresin E; Mele C; Breno M; Cuccarolo P; Alberti M; Valoti E; Piras R; Donadelli R; Vivarelli M; Murer L; Pecoraro C; Ferrari E; Perna A; Benigni A; Portalupi V; Remuzzi G
Am J Kidney Dis; 2019 Jul; 74(1):56-72. PubMed ID: 30851964
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical study of complement S protein (Vitronectin) in normal and diseased human kidneys: relationship to neoantigens of the C5b-9 terminal complex.
Bariety J; Hinglais N; Bhakdi S; Mandet C; Rouchon M; Kazatchkine MD
Clin Exp Immunol; 1989 Jan; 75(1):76-81. PubMed ID: 2467771
[TBL] [Abstract][Full Text] [Related]
6. Complement-mediated microangiopathy in IgA nephropathy and IgA vasculitis with nephritis.
Chua JS; Zandbergen M; Wolterbeek R; Baelde HJ; van Es LA; de Fijter JW; Bruijn JA; Bajema IM
Mod Pathol; 2019 Jul; 32(8):1147-1157. PubMed ID: 30936425
[TBL] [Abstract][Full Text] [Related]
7. Measurement of Complement Activation via Plasma-Soluble C5b-9 Comparison with Terminal Complement Complex Staining in a Series of Kidney Biopsies.
Wijaya C; Burns C; Hall S; Farmer M; Jones D; Rowlandson M; Choi P; Formby M; de Malmanche T
Kidney Blood Press Res; 2023; 48(1):220-230. PubMed ID: 36917968
[TBL] [Abstract][Full Text] [Related]
8. Eculizumab deposits in vessel walls in thrombotic microangiopathy.
Cassol CA; Brodsky SV; Satoskar AA; Blissett AR; Cataland S; Nadasdy T
Kidney Int; 2019 Sep; 96(3):761-768. PubMed ID: 31345584
[TBL] [Abstract][Full Text] [Related]
9. C5b-9 and adhesion molecules in human idiopathic membranous nephropathy.
Papagianni AA; Alexopoulos E; Leontsini M; Papadimitriou M
Nephrol Dial Transplant; 2002 Jan; 17(1):57-63. PubMed ID: 11773463
[TBL] [Abstract][Full Text] [Related]
10. Complement Activation and Thrombotic Microangiopathies.
Palomo M; Blasco M; Molina P; Lozano M; Praga M; Torramade-Moix S; Martinez-Sanchez J; Cid J; Escolar G; Carreras E; Paules C; Crispi F; Quintana LF; Poch E; Rodas L; Goma E; Morelle J; Espinosa M; Morales E; Avila A; Cabello V; Ariceta G; Chocron S; Manrique J; Barros X; Martin N; Huerta A; Fraga-Rodriguez GM; Cao M; Martin M; Romera AM; Moreso F; Manonelles A; Gratacos E; Pereira A; Campistol JM; Diaz-Ricart M
Clin J Am Soc Nephrol; 2019 Dec; 14(12):1719-1732. PubMed ID: 31694864
[TBL] [Abstract][Full Text] [Related]
11. Complement-mediated cellular injury.
Takano T; Elimam H; Cybulsky AV
Semin Nephrol; 2013 Nov; 33(6):586-601. PubMed ID: 24161043
[TBL] [Abstract][Full Text] [Related]
12. The pathogenetic significance of C5b-9 in IgA nephropathy.
Alexopoulos E; Papaghianni A; Papadimitriou M
Nephrol Dial Transplant; 1995; 10(7):1166-72. PubMed ID: 7478119
[TBL] [Abstract][Full Text] [Related]
13. Urinary excretion of the C5b-9 membrane attack complex of complement is a marker of immune disease activity in autologous immune complex nephritis.
Pruchno CJ; Burns MM; Schulze M; Johnson RJ; Baker PJ; Alpers CE; Couser WG
Am J Pathol; 1991 Jan; 138(1):203-11. PubMed ID: 1987766
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical studies of vitronectin, C5b-9, and vitronectin receptor in membranous nephropathy.
Ogawa T; Yorioka N; Yamakido M
Nephron; 1994; 68(1):87-96. PubMed ID: 7527506
[TBL] [Abstract][Full Text] [Related]
15. [Vitronectin in children with renal disease--1. Immunofluorescence study of vitronectin and C5b-9 in childhood IgA nephropathy].
Takahashi T; Inaba S; Okada T
Nihon Jinzo Gakkai Shi; 1995 Apr; 37(4):213-23. PubMed ID: 7541480
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical study of the membrane attack complex of complement and S-protein in idiopathic and secondary membranous nephropathy.
Lai KN; Lo ST; Lai FM
Am J Pathol; 1989 Sep; 135(3):469-76. PubMed ID: 2675624
[TBL] [Abstract][Full Text] [Related]
17. Localization of S protein and its relationship to the membrane attack complex of complement in renal tissue.
Falk RJ; Podack E; Dalmasso AP; Jennette JC
Am J Pathol; 1987 Apr; 127(1):182-90. PubMed ID: 2952015
[TBL] [Abstract][Full Text] [Related]
18. Terminal complement complex C5b-9 reduced megalin and cubilin-mediated tubule proteins uptake in a mouse model of trichloroethylene hypersensitivity syndrome.
Wang F; Huang LP; Dai YY; Huang M; Jiang W; Ye LP; Zhu QX
Toxicol Lett; 2019 Dec; 317():110-119. PubMed ID: 31618666
[TBL] [Abstract][Full Text] [Related]
19. Glomerular membrane attack complex is not a reliable marker of ongoing C5 activation in lupus nephritis.
Wilson HR; Medjeral-Thomas NR; Gilmore AC; Trivedi P; Seyb K; Farzaneh-Far R; Gunnarsson I; Zickert A; Cairns TD; Lightstone L; Cook HT; Pickering MC
Kidney Int; 2019 Mar; 95(3):655-665. PubMed ID: 30655025
[TBL] [Abstract][Full Text] [Related]
20. Role of the skin biopsy in the diagnosis of atypical hemolytic uremic syndrome.
Magro CM; Momtahen S; Mulvey JJ; Yassin AH; Kaplan RB; Laurence JC
Am J Dermatopathol; 2015 May; 37(5):349-56; quiz 357-9. PubMed ID: 25893747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
